BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Treatment
224 results:

  • 1. Survival and hormone production of isolated mouse follicles in three-dimensional artificial scaffolds after stimulation with bpV(HOpic).
    Keckstein P; Dittrich R; Bleisinger N; Hoffmann I; Beckmann MW; Gebhardt A; Schmid B; Keckstein S
    Arch Gynecol Obstet; 2024 May; 309(5):2127-2136. PubMed ID: 38472502
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Complexity of the Genetic Background of Oncogenesis in ovarian cancer-Genetic Instability and Clinical Implications.
    Murawski M; Jagodziński A; Bielawska-Pohl A; Klimczak A
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391958
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. β-Sitosterol targets ASS1 for Nrf2 ubiquitin-dependent degradation, inducing ROS-mediated apoptosis via the pten/PI3K/AKT signaling pathway in ovarian cancer.
    Wang H; Liu J; Zhang Z; Peng J; Wang Z; Yang L; Wang X; Hu S; Hong L
    Free Radic Biol Med; 2024 Mar; 214():137-157. PubMed ID: 38364944
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [News in breast oncology genetics for female and male population].
    Taris N; Luporsi E; Osada M; Thiblet M; Mathelin C
    Gynecol Obstet Fertil Senol; 2024 Mar; 52(3):149-157. PubMed ID: 38190969
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
    Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
    Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells.
    Ravindran F; Mhatre A; Koroth J; Narayan S; Choudhary B
    Life Sci; 2023 Dec; 334():122224. PubMed ID: 38084671
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in ovarian cancer.
    Heo J; Kim YN; Shin S; Lee K; Lee JH; Lee YJ; Choi Z; Park J; Min S; Kim SW; Choi JR; Kim S; Lee ST; Lee JY
    Cancer Res; 2024 Feb; 84(3):468-478. PubMed ID: 38038965
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Umbilical Cord Blood-Derived M1 Macrophage Exosomes Loaded with Cisplatin Target ovarian cancer
    Zhang X; Wang J; Liu N; Wu W; Li H; Lu W; Guo X
    Mol Pharm; 2023 Nov; 20(11):5440-5453. PubMed ID: 37819754
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. FOXO3 and pten expression in the ovary of girls with extra-gonadal cancer with or without chemotherapy treatment prior to cryopreservation.
    Albamonte MI; Calabró LY; Albamonte MS; Vitullo AD
    BMC Womens Health; 2023 Sep; 23(1):509. PubMed ID: 37737182
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular biological analysis revealed a case of synchronous endometrial and ovarian cancer with different histological grade as metastatic ovarian cancer from endometrial cancer: Case report and review of literature.
    Yumisashi R; Saito R; Togami S; Kobayashi Y; Kitazono I; Tanimoto A; Kobayashi H
    J Obstet Gynaecol Res; 2023 Nov; 49(11):2766-2770. PubMed ID: 37604499
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancer.
    Kitazawa S; Chiyoda T; Nakamura K; Sakai K; Yoshihama T; Nishio H; Kobayashi Y; Iwata T; Banno K; Yamagami W; Nishihara H; Aoki D
    Int J Clin Oncol; 2023 Nov; 28(11):1554-1562. PubMed ID: 37574505
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
    Öfverholm A; Törngren T; Rosén A; Arver B; Einbeigi Z; Haraldsson K; Ståhlbom AK; Kuchinskaya E; Lindblom A; Melin B; Paulsson-Karlsson Y; Stenmark-Askmalm M; Tham E; von Wachenfeldt A; Kvist A; Borg Å; Ehrencrona H
    BMC Cancer; 2023 Aug; 23(1):738. PubMed ID: 37563628
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Anticancer Effect of Enterococcus faecium, Isolated from Vaginal Fluid, on ovarian cancer Cells.
    Pourmollaei S; Farshbaf-Khalili A; Barzegari A; Bastani S; Babaie S; Fattahi A; Shahnazi M
    Iran Biomed J; 2023 Jul; 27(4):205-13. PubMed ID: 37525437
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Evolving Spectrum of Endometrial Glandular Proliferations With Corded and Hyalinized Features.
    Pors J; Weiel JJ; Ryan E; Longacre TA
    Am J Surg Pathol; 2023 Sep; 47(9):1067-1076. PubMed ID: 37493099
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Dominant Mechanism of Cyclophosphamide-Induced Damage to ovarian Reserve: Premature Activation or Apoptosis of Primordial Follicles?
    Xie Q; Liao Q; Wang L; Zhang Y; Chen J; Bai H; Li K; Ai J
    Reprod Sci; 2024 Jan; 31(1):30-44. PubMed ID: 37486531
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Hsa_circ_0001535 inhibits the proliferation and migration of ovarian cancer by sponging miR-593-3p, upregulating pten expression.
    Han Y; Zheng Y; You J; Han Y; Lu X; Wang X; Shi C; Zhu W
    Clin Transl Oncol; 2023 Oct; 25(10):2901-2910. PubMed ID: 37000289
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Anticancer Effect of Active Component of Astragalus Membranaceus Combined with Olaparib on ovarian cancer Predicted by Network-Based Pharmacology.
    Liu Y; Guo Z; Lang F; Li J; Jiang J
    Appl Biochem Biotechnol; 2023 Nov; 195(11):6994-7020. PubMed ID: 36976504
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. pten mutation predicts unfavorable fertility preserving treatment outcome in the young patients with endometrioid endometrial cancer and atypical hyperplasia.
    Xue Y; Dong Y; Lou Y; Lv Q; Shan W; Wang C; Chen X
    J Gynecol Oncol; 2023 Jul; 34(4):e53. PubMed ID: 36929579
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Prevalence of Pathogenic Germline Mutations in 13 Hereditary cancer-Related Genes in Breast cancer Patients in Narathiwat Province, Thailand.
    Sukpan P; Kanokwiroon K; Sriplung H; Laochareonsuk W; Choochuen P; Auseng N; Wanawanakorn K; Sangkhathat S
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):525-530. PubMed ID: 36853301
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Lineage tracing of mutant granulosa cells reveals in vivo protective mechanisms that prevent granulosa cell tumorigenesis.
    Niu S; Cheng K; Jia L; Liang J; Mu L; Wang Y; Yang X; Yang C; Zhang Y; Wang C; Huang L; Wang H; Zhang S; Zhang H
    Cell Death Differ; 2023 May; 30(5):1235-1246. PubMed ID: 36823373
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.